Microarray-Based Allergy Diagnosis: Quo Vadis?

Microarray-Based Allergy Diagnosis: Quo Vadis?

More than 30% of the world population suffers from allergy. Allergic individuals are characterized by the production of immunoglobulin E (IgE) antibodies against innocuous environmental allergens. Upon allergen recognition IgE mediates allergen-specific immediate and late-phase allergic inflammation...

Full description

Bibliographic Details
Main Authors: Huey-Jy Huang, Raffaela Campana, Oluwatoyin Akinfenwa, Mirela Curin, Eszter Sarzsinszky, Antonina Karsonova, Ksenja Riabova, Alexander Karaulov, Katarzyna Niespodziana, Olga Elisyutina, Elena Fedenko, Alla Litovkina, Evgenii Smolnikov, Musa Khaitov, Susanne Vrtala, Thomas Schlederer, Rudolf Valenta
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
allergy
allergen
IgE
molecular diagnosis
microarrayed allergens
allergen chip
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.594978/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2020.594978/full

Similar Items